Related Experiment Video
Updated: Jan 31, 2026

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
Published on: June 5, 2020
Antibody Repertoire Analysis of Hepatitis C Virus Infections Identifies Immune Signatures Associated With Spontaneous
Sivan Eliyahu1, Oz Sharabi2, Shiri Elmedvi1
1Molecular Virology Lab, The Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Insights
Hepatitis C virus (HCV) infection outcomes can be predicted by analyzing adaptive immune receptor repertoires. Distinct antibody clusters in spontaneous clearers (SC) were identified, aiding in the development of neutralizing antibodies for potential immunotherapies and vaccines.
Area of Science:
- Immunology
- Virology
- Computational Biology
Background:
- Hepatitis C virus (HCV) infects over 70 million globally, risking severe liver disease.
- No vaccine exists, and immune responses to HCV, particularly spontaneous clearance (SC) versus chronic infection (CI), are poorly understood.
- Understanding immune differences between SC and CI individuals can reveal mechanisms of viral control.
Purpose of the Study:
- To analyze adaptive immune receptor repertoires in individuals with current or past HCV infection.
- To compare immune responses between spontaneous clearers (SC) and chronically infected (CI) individuals.
- To identify mechanisms governing viral infection outcomes and develop novel immunotherapies.
Main Methods:
- In-depth analysis of adaptive immune receptor repertoires.
- Machine learning framework utilizing antibody characteristics to predict infection outcome.
- Combinatorial antibody phage display library technology to identify HCV-specific antibody sequences.
Main Results:
- SC individuals exhibit distinct antibody clusters compared to CI patients.
- Antibody characteristics accurately predicted HCV infection outcomes using a machine learning model.
- Two novel antibodies with high neutralization breadth, associated with viral clearance, were constructed.
Conclusions:
- Distinct adaptive immune responses, particularly antibody profiles, differentiate spontaneous HCV clearance from chronic infection.
- Machine learning and antibody engineering approaches can predict infection outcomes and generate effective neutralizing antibodies.
- Findings offer insights into effective immune responses against HCV, potentially guiding prognosis, immunotherapy, and vaccine design.
Abstract:
Hepatitis C virus (HCV) is a major public health concern, with over 70 million people infected worldwide, who are at risk for developing life-threatening liver disease. No vaccine is available, and immunity against the virus is not well-understood. Following the acute stage, HCV usually causes chronic infections. However, ~30% of infected individuals spontaneously clear the virus. Therefore, using HCV as a model for comparing immune responses between spontaneous clearer (SC) and chronically infected (CI) individuals may empower the identification of mechanisms governing viral infection outcomes. Here, we provide the first in-depth analysis of adaptive immune receptor repertoires in individuals with current or past HCV infection. We demonstrate that SC individuals, in contrast to CI patients, develop clusters of antibodies with distinct properties. These antibodies' characteristics were used in a machine learning framework to accurately predict infection outcome. Using combinatorial antibody phage display library technology, we identified HCV-specific antibody sequences. By integrating these data with the repertoire analysis, we constructed two antibodies characterized by high neutralization breadth, which are associated with clearance. This study provides insight into the nature of effective immune response against HCV and demonstrates an innovative approach for constructing antibodies correlating with successful infection clearance. It may have clinical implications for prognosis of the future status of infection, and the design of effective immunotherapies and a vaccine for HCV.
Related Concept Videos
Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance
Most drugs undergo restrictive clearance, which is proportional to the...
Hepatic Drug Clearance: Role of Transporters
Hepatic Drug Clearance: Effect of Protein Binding
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
Spontaneity
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
What is the Immune System?

